Related references
Note: Only part of the references are listed.Cell surface-tethered IL-12 repolarizes the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
Douglas S. Jones et al.
SCIENCE ADVANCES (2022)
Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages
Tushuai Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in Mice
Anjali Barnwal et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)
IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines
Zhiliang Jia et al.
FRONTIERS IN IMMUNOLOGY (2022)
IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar et al.
CANCERS (2021)
DC-Derived Exosomes for Cancer Immunotherapy
Yi Yao et al.
CANCERS (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy
Jieyu Li et al.
CELLULAR IMMUNOLOGY (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
Aslan Mansurov et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance
Xin Zhao et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Origin and Functions of Exosomes in Cancer
Chitra Rajagopal et al.
FRONTIERS IN ONCOLOGY (2018)
Recent advancements in the use of exosomes as drug delivery systems
Edwin J. Bunggulawa et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27
Norberto Walter Zwirner et al.
FRONTIERS IN IMMUNOLOGY (2017)
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
Dinh Ha et al.
ACTA PHARMACEUTICA SINICA B (2016)
Exosomes as drug delivery vehicles for Parkinson's disease therapy
Matthew J. Haney et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells
Qingsheng Li et al.
JOURNAL OF IMMUNOLOGY (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
The Spleen in Local and Systemic Regulation of Immunity
Vincenzo Bronte et al.
IMMUNITY (2013)
The integration of T cell migration, differentiation and function
David Masopust et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis
Catherine E. Steding et al.
IMMUNOLOGY (2011)
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
Michael S. Sabel et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
Matthew E. Pipkin et al.
IMMUNITY (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
Interleukin 12 Stimulates IFN-γ-Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance
Xuefang Cao et al.
CANCER RESEARCH (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo
Stephanie K. Watkins et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation
DP Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients
N Haicheur et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
